We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04845178
Recruitment Status : Recruiting
First Posted : April 14, 2021
Last Update Posted : March 8, 2023
Information provided by (Responsible Party):
AEON Biopharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 15, 2023
Estimated Study Completion Date : February 13, 2024